Loading...
Policy2019-03-07T15:00:49+00:00

Add your voice to the thousands across the country telling Congress to support The Immunosuppressive Drug Coverage for Kidney Transplant Patients Act.

In 1972, Congress made a commitment to cover treatment for patients with end-stage renal disease (ESRD) regardless of their age or disability status. Today, Medicare covers the costs for an ESRD patient to receive a transplant but only covers their anti-rejection medication – one of the key factors that ensures long-term organ health – for 3 years after surgery.

The problem is costly

If a patient cannot afford their medications, the transplanted kidney will be rejected and the patient will have to return to dialysis – a costly and burdensome treatment that reduces the patient’s overall health outcomes and quality of life.

More than 70% of U.S. kidney-transplantation programs reported that their patients had difficulties paying for immunosuppressive medications.

Legislative tracker

How close are we to passing the bill? And how can I help?

Below are important milestones for advancing a bill into law. At each point, we need your support to urge Congress to take specific actions. We’ll keep track of progress right here.

Stay up-to-speed on the progress of our bill by joining the email list and signing the petition.

The solution is simple

The Immunosuppressive Drug Coverage for Kidney Transplant Patients Act would be a straightforward solution to an unnecessary problem.

This bipartisan legislation will:

  • Allow kidney transplant recipients to continue to receive Medicare coverage for the purpose of immunosuppressive drugs only

  • Reduce the need for dialysis – a costly and burdensome treatment – and repeated kidney transplants, saving both lives and money over time

There is broad community support for this bill

The following groups support this legislation:

  • National Kidney Foundation

  • American Society of Transplant Surgeons

  • American Society of Transplantation

  • American Society of Nephrology

  • American Society of Pediatric Nephrology

  • American Association of Kidney Patients

  • Association of Organ Procurement Organizations

  • Dialysis Patient Citizens

  • Renal Physicians Association

  • United Network for Organ Sharing

The benefits are clear

  • The patient will live a longer and happier life

  • The donor and their family will feel that their sacrifice was worth the cost

  • Medicare will save an estimated $200 million annually if anti-rejection medication was provided for the lifetime of the organ

Congress must act

Congress can and must do better to protect people living with transplants, honor their donors, and save Medicare money. This bill has been introduced 14 times in the past 15 years. Let’s make 2019 the year that this finally passes!

TAKE ACTION